Efficacy of Empagliflozin and Pioglitazone in Diabetic Patients With NAFLD
Conditions:   Non-Alcoholic Fatty Liver Disease;   Type2diabetes Interventions:   Drug: Empagliflozin 10 MG;   Drug: Pioglitazone 15mg;   Drug: Metformin Sponsor:   Jinnah Postgraduate Medical Centre Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 12, 2023 Category: Research Source Type: clinical trials

Effect at 3 Months of Early Empagliflozin Initiation in Cardiogenic Shock Patients on Mortality, Rehospitalization, Left Ventricular Ejection Fraction and Renal Function.
Condition:   Cardiogenic Shock Intervention:   Drug: Empagliflozin 10 MG Sponsor:   Central Hospital, Nancy, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 30, 2023 Category: Research Source Type: clinical trials